Making proteomics 100x more robust and 10x faster
A targeted therapy shows it can offer a ‘last, great chance’ for some acute leukemia patients
SAN DIEGO — One of the toughest subtypes of acute leukemia involves a genetic alteration in the KMT2A gene. Many cancers with this genetic alteration